Papers - ICHIKAWA Hiroaki
-
Incidence and predictors for symptomatic stroke within 30 days after transcatheter aortic valve implantation: insights from the LAPLACE-TAVI registry.
Yokoyama H, Yamazaki K, Shikanai S, Hamadate M, Tsushima M, Narita N, Senoo M, Ichikawa H, Shibutani S, Hanada K, Saito Y, Murata K, Imamura Y, Higuchi R, Hagiya K, Takamisawa I, Nanasato M, Iguchi N, Takayama M, Shimizu J, Tamura H, Doi S, Okazaki S, Ishiyama M, Fukutomi M, Takanashi S, Saji M, Minakawa M, Tomita H
Journal of cardiology 2026.2
-
Impact of Preoperative Diuretics Treatment on Long-Term Clinical Outcomes After Transcatheter Aortic Valve Implantation
Hirosawa Shun, Yokoyama Hiroaki, Yamazaki Ken, Shikanai Shun, Tsushima Michiko, Narita Noritomo, Senoo Maiko, Ichikawa Hiroaki, Shibutani Shuji, Hanada Kenji, Saito Yoshiaki, Murata Kenyu, Imamura Yuki, Higuchi Ryosuke, Hagiya Kenichi, Takamisawa Itaru, Nanasato Mamoru, Iguchi Nobuo, Takayama Morimasa, Shimizu Jun, Tamura Harutoshi, Doi Shinichiro, Okazaki Shinya, Ishiyama Masaki, Fukutomi Motoki, Takanashi Shuichiro, Saji Mike, Minakawa Masahito, Tomita Hirofumi
International Heart Journal 67 ( 1 ) 27 - 34 2026.1
-
Impact of preprocedural atrial fibrillation and body mass index on clinical outcomes after transcatheter aortic valve implantation.
Umezaki H, Yokoyama H, Hirosawa S, Yamazaki K, Shikanai S, Hamadate M, Tsushima M, Senoo M, Narita N, Ichikawa H, Shibutani S, Hanada K, Murata K, Imamura Y, Saito Y, Minakawa M, Tomita H
Heart and vessels 2025.12
-
特集 検体検査のポイントとピットフォール 診察室にこの1冊 B.確定診断に用いる検査 10.心筋傷害マーカー(トロポニンなど)[生化学的検査]
市川 博章, 富田 泰史
診断と治療 113 ( 13 ) 217 - 220 2025.3
-
Incidence and Predictors of Appropriate Implantable Cardioverter Defibrillator Therapy in Japanese Ischemic Heart Disease Patients
Hanada Kenji, Sasaki Shingo, Kinjo Takahiko, Shikanai Shun, Yamazaki Ken, Kato Tomo, Tsushima Michiko, Senoo Maiko, Narita Noritomo, Ichikawa Hiroaki, Shibutani Shuji, Yokoyama Hiroaki, Yokota Takashi, Okumura Ken, Tomita Hirofumi
Circulation Journal 89 ( 3 ) 354 - 363 2025.2
-
Sleep Quality is a Predictor of Hospitalization-Acquired Functional Decline after Transcatheter Aortic Valve Implantation：A Prospective Observational Study
Ishioka Shinji, Yokota Junichi, Morikawa Natsuka, Watanabe Nao, Shirakawa Mio, Kawagishi Ryo, Seki Shiori, Narita Noritomo, Ichikawa Hiroaki, Yokoyama Hiroaki, Tomita Hirofumi, Tsuda Eiichi
Journal of Japanese Cardiovascular Physical Therapy advpub ( 0 ) 2025
-
Incidence, Predictors, and Outcome Associated With Ventricular Tachycardia or Fibrillation in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction
Hanada Kenji, Kinjo Takahiko, Yokoyama Hiroaki, Tsushima Michiko, Senoo Maiko, Ichikawa Hiroaki, Nishizaki Fumie, Shibutani Shuji, Yokota Takashi, Okumura Ken, Tomita Hirofumi
Circulation Journal 88 ( 8 ) 1254 - 1264 2024.7
-
Serial longitudinal changes of coronary calcified plaques with clear outer borders under intensive lipid management: insights from optical coherence tomography.
Takanobu Soma, Hiroaki Yokoyama, Kazumasa Saito, Shota Washima, Michiko Tsushima, Maiko Senoo, Hiroaki Ichikawa, Fumie Nishizaki, Shuji Shibutani, Kenji Hanada, Hirofumi Tomita
Heart and vessels 39 ( 5 ) 373 - 381 2024.5
-
Comparison of procedural and clinical outcomes between optical coherence tomography and intravascular ultrasound guided percutaneous coronary intervention for patients with acute coronary syndrome
Shikanai Shun, Yokota Takashi, Yokoyama Hiroaki, Soma Takanobu, Sakai Shuntaro, Sorimachi Yuya, Hamaura Shogo, Yamazaki Ken, Tsushima Michiko, Senoo Maiko, Ichikawa Hiroaki, Nishizaki Fumie, Shibutani Shuji, Hanada Kenji, Tomita Hirofumi
Hirosaki Medical Journal 74 ( 1-4 ) 6 - 16 2024.3
-
Impact of Triglyceride Levels on the Long-term Clinical Outcomes in Patients With Acute Myocardial Infarction.
Kazufumi Kato, Hiroaki Yokoyama, Toshihiro Iwasaki, Yuki Konno, Ken Yamazaki, Shun Shikanai, Tomo Kato, Michiko Tsushima, Maiko Senoo, Noritomo Narita, Hiroaki Ichikawa, Shuji Shibutani, Kenji Hanada, Hirofumi Tomita
In vivo (Athens, Greece) 38 ( 6 ) 3078 - 3084 2024
-
Delayed coronary artery stenosis: a rare complication of the left atrial clipping device.
Yuki Imamura, Ryosuke Kowatari, Tomonori Kawamura, Hiroaki Ichikawa
Interdisciplinary cardiovascular and thoracic surgery 37 ( 5 ) 2023.11
-
Reduced Left Ventricular Ejection Fraction Is a Risk for Sudden Cardiac Death in the Early Period After Hospital Discharge in Patients With Acute Myocardial Infarction
Hanada Kenji, Sasaki Shingo, Seno Maiko, Kimura Yoshihiro, Ichikawa Hiroaki, Nishizaki Fumie, Yokoyama Hiroaki, Yokota Takashi, Okumura Ken, Tomita Hirofumi
Circulation Journal 86 ( 10 ) 1490 - 1498 2022.9
-
Early Initiation of Venovenous Extracorporeal Membrane Oxygenation for Critically Ill COVID-19 Patients.
Takeshi Goto, Shinya Yaguchi, Junko Ogasawara, Naotaka Kato, Jin Irie, Hiroaki Ichikawa, Yuki Nishiya, Yoshiya Ishizawa, Osamu Nomura, Hiroyuki Hanada
The journal of extra-corporeal technology 54 ( 1 ) 79 - 82 2022.3
-
Two Cases of Suspected Cardiac Papillary Fibroelastoma Detected by Transesophageal Echocardiography During Transcatheter Aortic Valve Implantation
Sakai Shuntaro, Yokoyama Hiroaki, Ichikawa Hiroaki, Kimura Yoshihiro, Nishizaki Fumie, Hanada Kenji, Yokota Takashi, Yamada Masahiro, Tomita Hirofumi
Shinzo 54 ( 1 ) 100 - 105 2022.1
-
Rivaroxaban attenuates cardiac hypertrophy by inhibiting protease-activated receptor-2 signaling in renin-overexpressing hypertensive mice.
Masato Narita, Kenji Hanada, Yosuke Kawamura, Hiroaki Ichikawa, Shuntaro Sakai, Yoshikazu Yokono, Maiko Senoo, Noritomo Narita, Michiko Shimada, Tomohiro Osanai, Ken Okumura, Hirofumi Tomita
Hypertension research : official journal of the Japanese Society of Hypertension 44 ( 10 ) 1261 - 1273 2021.7
-
Rivaroxaban, a Direct Factor Xa Inhibitor, Ameliorates Hypertensive Renal Damage Through Inhibition of the Inflammatory Response Mediated by Protease-Activated Receptor Pathway
Hirosaki Medical Journal 71 ( 1 ) 89 - 91 2020
-
Rivaroxaban, a Direct Factor Xa Inhibitor, Ameliorates Hypertensive Renal Damage Through Inhibition of the Inflammatory Response Mediated by Protease-Activated Receptor Pathway.
Hiroaki Ichikawa, Michiko Shimada, Masato Narita, Ikuyo Narita, Yoshihiro Kimura, Makoto Tanaka, Tomohiro Osanai, Ken Okumura, Hirofumi Tomita
Journal of the American Heart Association 8 ( 8 ) e012195 2019.4
-
Blood Pressure-Independent Effect of Olmesartan on Albuminuria in Mice Overexpressing Renin Its Beneficial Role in the ACE2/Ang (1-7)/Mas Axis and NADPH Oxidase Expression
Hiroaki Ichikawa, Ikuyo Narita, Masato Narita, Tomohiro Tanno, Yoshikazu Yokono, Yoshihiro Kimura, Makoto Tanaka, Tomohiro Osanai, Ken Okumura and Hirofumi Tomita
International Heart Journal 2018.11
-
〈一般演題抄録〉リバーロキサバンによるアンジオテンシンII 誘発ヒトポドサイト障害の改善効果
金澤 卓也, 市川 博章, 成田 真人, 島田 美智子, 富田 泰史
弘前医学 68 ( 2 ) 2018
-
Relationship Between Serum Eicosapentaenoic Acid Levels and J-Waves in a General Population in Japan:Analysis of the Iwaki Health Promotion Project
Kimura Yoshihiro, Kurauchi Shizuka, Nakaji Shigeyuki, Okumura Ken, Tomita Hirofumi, Yamada Masahiro, Hanada Kenji, Endo Tomohide, Narita Noritomo, Narita Masato, Senoo Maiko, Yonekura Manabu, Ichikawa Hiroaki
International Heart Journal 59 ( 4 ) 736 - 740 2018
-
Olmesartan Inhibits Cardiac Hypertrophy in Mice Overexpressing Renin Independently of Blood Pressure: Its Beneficial Effects on ACE2/Ang(1-7)/Mas Axis and NADPH Oxidase Expression.
Tanno T, Tomita H, Narita I, Kinjo T, Nishizaki K, Ichikawa H, Kimura Y, Tanaka M, Osanai T, Okumura K
Journal of cardiovascular pharmacology 67 ( 6 ) 503 - 9 2016.6
-
Enhanced p122RhoGAP/DLC-1 Expression Can Be a Cause of Coronary Spasm.
Kinjo T, Tanaka M, Osanai T, Shibutani S, Narita I, Tanno T, Nishizaki K, Ichikawa H, Kimura Y, Ishida Y, Yokota T, Shimada M, Homma Y, Tomita H, Okumura K
PloS one 10 ( 12 ) e0143884 2015
-
Antibacterial and antifungal activities of isoprenoids
Nagaki Masahiko, Narita Takashi, Ichikawa Hiroaki, Kawakami Jun, Nakane Akio
Transactions of the Materials Research Society of Japan 36 ( 1 ) 55 - 58 2011